Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
Advances in Therapy|October 12, 2023
Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational StudyLi Ying, Ji Suyun, Liang Yanhua, et al.
International Immunopharmacology|September 28, 2024
Investigating the molecular mechanisms between type 1 diabetes and mild cognitive impairment using bioinformatics analysis, with a focus on immune responseDongxu Yue, Runze Wang, Yanli Zhao, et al.
The Journal of Dermatological Treatment|October 1, 2025
Clinical efficacy, drug retention and recurrence of ixekizumab across psoriasis severities: a multicenter retrospective analysis of 354 patientsZhuhui Qiao, Bao Chai, Yu Chen, et al.
Drug Safety|April 30, 2024
The Safety of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: Analyses from a Prospective, Single-Arm, Multicenter, 12-Week Observational StudyYing Li, Lin Dang, Chengzhi Lv, et al.
Zhonghua Nei Ke Za Zhi|August 14, 2015
[An analysis of amino acid metabolic profile and its clinical significance in ulcerative colitis]Limin Xin, Nan Li, Wentao Zhu, et al.
The Journal of Investigative Dermatology|December 17, 2020
OVOL1 Regulates Psoriasis-Like Skin Inflammation and Epidermal HyperplasiaPeng Sun, Remy Vu, Morgan Dragan, et al.
International Immunopharmacology|November 16, 2025
Cryptochrome 2 stabilization alleviates psoriasis by inhibiting keratinocyte hyperproliferation and inflammationLingling Yao, Lian Cui, Qianyu Chen, et al.
Dermatology and Therapy|March 27, 2024
Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World StudyYing Li, Chengzhi Lv, Lin Dang, et al.
Chinese Medical Journal|May 6, 2024
Clinical characteristics and outcomes of psoriasis patients with COVID-19: A retrospective, multicenter cohort study in ChinaYanhua Liu, Zhongrui Xu, Jian Zhou, et al.
Psoriasis (Auckland, N.Z.)|June 1, 2026
Development of Predictive Models for NB-UVB Treatment Efficacy and Safety in PsoriasisYingyuan Yu, Bingjie Li, Yu Wang, et al.
Pageof 20